Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis

por Cardner, Mathias, Tuckwell, Danny, Kostikova, Anna, Forrer, Pascal, Siegel, Richard M, Marti, Alain, Vandemeulebroecke, Marc, Ferrero, Enrico
Publicado 2023

Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study

por Magnolo, Nina, Kingo, Külli, Laquer, Vivian, Browning, John, Reich, Adam, Szepietowski, Jacek C., Keefe, Deborah, Papanastasiou, Philemon, Bao, Weibin, Forrer, Pascal, Patekar, Manmath
Publicado 2022

Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials

por Sticherling, Michael, Nikkels, Arjen F., Hamza, Ashraf M., Kwong, Pearl, Szepietowski, Jacek C., El Sayed, Mahira, Ghislain, Pierre-Dominique, Khotko, Alkes A., Patekar, Manmath, Ortmann, Christine-Elke, Forrer, Pascal, Papanastasiou, Philemon, Keefe, Deborah
Publicado 2023